MAM
Roopak Saluja joins speaker line-up at Adfest 2016
MUMBAI: The 120 Media Collective and Sooperfly founder & CEO Roopak Saluja will present a session on “Content is King. Distribution is God!” at Adfest 2016.
Saluja’s session will examine whether the distribution, monetisation, engagement and promotion of content deserves more focus.
“The wisdom of investing not just in content but in platform creation and longer-term audience building is rapidly striking brands the world over. As we navigate the flux, new business models evolve and hybrid organisations emerge, ones that allow for the building of content brands direct-to-audiences,” says Saluja.
“During my session at Adfest, I’d like to take the audience on a journey to help them see how distribution is emerging as the battleground for engagement. The lines have blurred between platforms and screens, bringing creators and audiences closer together than ever before,” he added.
After beginning his career in account management at Young & Rubicam Budapest, Saluja became an entrepreneur in 2006 with the launch of Bang Bang Films. Post that he launched two other subsidiaries – Jack in the Box Worldwide and Sniper, which now form The 120 Media Collective. Most recently, he launched Sooperfly, a new media company that empowers Asia’s digital video ecosystem by building content brands direct-to-audiences.
“Roopak has successfully switched from advertising to entrepreneurialism and is now leading one of India’s fastest growing content production companies. I think delegates at Adfest this year will learn so much from his session about the art of blurring the lines between communications, entertainment and technology,” said Adfest president Jimmy Lam.
Saluja’s session will be held on 17 March. Adfest 2016 will be held from 16 to 19 March at the Royal Cliff Hotels Group in Pattaya, Thailand.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
